>BIOME9 is a pioneering pet care startup founded in 2023 and headquartered in the United Kingdom. The company's mission is to revolutionize pet care by leveraging personalized, data-driven solutions. Using advanced science and AI, BIOME9 aims to decode the complexities of the gut microbiome to provide tailored dietary and nutritional recommendations for dogs. The company's flagship product, GutDiscovery®, offers an at-home gut microbiome test that provides insights into the specific nutritional needs of each dog. BIOME9's InvisibleHealth™ algorithm utilizes state-of-the-art generative AI to process vast amounts of data, creating personalized care plans based on the pet's unique biological makeup. The results from the test provide a personalized report with a tailored nutritional plan and precision supplement program, designed to address various health aspects such as digestive issues, joint health, immunity, and early health-risk detection. The startup recently secured a Seed Round investment on 01 January 2024 from Stonebridge PLC, indicating early investor interest in its innovative approach to pet health. As BIOME9 continues to lead the pet care revolution, its dedication to research and technology-driven solutions positions it to offer a cutting-edge, personalized approach to pet nutrition, ensuring pets enjoy optimal health and happiness.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 | Stonebridge PLC | 01 Jan 2024 |
No recent news or press coverage available for BIOME9.
We care about your data, and we'd love to use cookies make your experience better.